BAG3 and metabolic dysfunction-associated steatotic liver disease: Overall, our results support the hypothesis that BAG3 could act as a stress-induced biomarker likely linking genetic susceptibility and fibrotic remodeling in MASLD, although longitudinal studies are necessary to confirm its prognostic role.